Development and use of quality of care indicators for obstetric care in women with preeclampsia, severe preeclampsia, and severe morbidity

Hypertension in Pregnancy

Volumn 26, Issue 3, 2007, Pages 241-257

  Pérez Cuevas, Ricardo ^a,b   Morales, Hortensia Reyes ^a   Doubova, Svetlana Vladislavovna ^a   Murillo, Vitelio Velasco ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b NONE   (Mexico)

Author keywords

Indicators; Preeclampsia; Quality of care

Indexed keywords

ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; DEXAMETHASONE; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; PHENYTOIN;

ADOLESCENT; ADULT; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; CONVULSION; DELIVERY; DISEASE SEVERITY; FEMALE; GESTATIONAL AGE; HEALTH CARE QUALITY; HOSPITAL ADMISSION; HUMAN; HYPERTENSION; INTENSIVE CARE; LABORATORY TEST; MAJOR CLINICAL STUDY; MORBIDITY; OBSTETRIC CARE; PREECLAMPSIA; SEIZURE; UNSPECIFIED SIDE EFFECT; VALIDATION PROCESS;

ADOLESCENT; ADULT; DELIVERY, OBSTETRIC; FEMALE; HUMANS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT ADMISSION; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; QUALITY INDICATORS, HEALTH CARE;

EID: 34548095682     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.1080/10641950701356784     Document Type: Article

References (29)

1. Sibai BM, Caritis S, Hauth J. What we have learned about preeclampsia. Semin Perinatol 2003; 27(3):239-246.
2. Walsh J, Feifer Ch, Measham A, Gertler P. Maternal and perinatal health, In: Disease Control Priorities in Developing Countries. Jamison D, Mosley H, Measham A, Bobadilla JL, eds. Washington DC: The World Bank, Oxford Medical Publications; 1993, 363-390.
3. Gülmezoglu AM, Say L, Betrán AP, Villar J, Piaggio G. WHO systematic review of maternal mortality and morbidity: methodological issues and challenges. BMC Medical Research Methodology 2004; 4:16. http://www. biomedcentral.com/1471-2288/4/16
4. Lopez-Jaramillo P, Casas JP, Serrano N. Preeclampsia: from epidemiological observations to molecular mechanisms. Braz J Med Biol Res 2001; 34(10):1227-1235.
5. Pan American Health Organization, Reported Maternal Mortality Rate Tasbulator. http://www.paho.org/English/SHA/coredata/tabulator/newsq/Tabulador. asp (April 26, 2002)
6. Jowett M. Safe Motherhood interventions in low-income countries: an economic justification and evidence of cost effectiveness. Health Policy 2000; 53:201-228.
7. Donabedian A. The definition of quality and approaches to its management. Vol I Exploration in quality assessment and monitoring. Ann Arbor, Michigan: Health Administration Press; 1980, 38-41.
8. Filippi V, Brugha R, Browne E, Gohou V, Bacci A, De Brouwere V, Sahel A, Goufodji S, Alihonou E, Carine R. Obstetric audit in resource-poor settings: lessons from a multi-country project auditing "near miss" obstetrical emergencies. Health Policy Plan 2004; 19 (1):57-66.
9. Brook RH. The RAND/UCLA appropriateness method. In Methodology perspectives, edited by McCormick KA, Moore S, Siegel RA.; AHCPR Pub. No. 95-0009. Rockville, MD: Public Health Service, US Department of Health and Human Services; 1994; 59-70.
10. Pérez-Cuevas R, Fraser W, Reyes H, Reinharz D, Daftari A, Heinz C, Roberts J. Critical pathways for the management of preeclampsia and severe preeclampsia in institutionalized health care settings. BMC Pregnancy Childbirth 2003;3:6.
11. Integrated management of pregnancy and childbirth. Pregnancy, Childbirth, Postpartum and Newborn Care: A guide for essential practice. Geneva: World Health Organization, 2003.
12. National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. NIH Publication No. 00-3029. National Institutes of Health, 2000.
13. Lindheimer M, Roberts J, Cunningham F. Chesley's Hypertensive Disorders in Pregnancy. 2nd ed. Appleton & Lange; 1999.
14. Helewa M, Burrows R, Smith J, Williams K, Brain P, Rabkin S. Report on the Canadian Hypertension Society Consensus Conference:1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 1997, 157:715-725.
15. Montan S, Anandakumar C, Arulkumaran S. Effects of methyldopa on uteroplacental and fetal haemodynamic in pregnancy-induced hypertension. Am J Obstet Gynecol 1993; 168:152-156.
16. st Ed. New York: McGraw-Hill; 2001, 567-618.
17. Pridjian G, Puschett J: Preeclampsia. Part I. Clinical and pathophysiologic considerations. Obstetr Gyneco Survey 2002; 52(9):598-618.
18. Martius JA, Steck T, Oehler MK, Wulf KH. Risk factors associated with pre-term (<370 weeks) and early pre-term birth (<320 weeks): univariate and multivariate analysis of 106,345 singleton births from the 1994 state wide perinatal survey of Bavaria. Eur J Obstet Gynecol Reprod Biol 1998; 80:183-189.
19. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinatol 1991; 18:661-682.
20. Hauth JC, Ewell MG, Levine RJ, Esterlitz JR, Sibai B, Curet LB, Catalano PM, Morris CD. (Calcium for Preeclampsia Prevention Study Group): Pregnancy outcomes in healthy nulliparas who developed hypertension. Obstet Gynecol 2000; 95:24.
21. Ray JG, Burrows RF, Burrows EA, Vermeulen MJ. MOS HIP: McMaster outcome study of hypertension in pregnancy. Early Hum Dev 2001; 64:129-143.
22. Velasco V. Pozos J. Avances en la prevención y tratamiento de la preeclampsia-eclampsia. In Prioridades de Salud en la Mujer, edited by Velasco V, Reyes A. México: Instituto Mexicano del Seguro Social; 2002, 153-166.
23. División Técnica de Información Estadística en Salud. Dirección de Prestaciones Médicas. Clasificación de los recién nacidos por edad gestacional y peso. Enero-Diciembre 2002. México: Instituto Mexicano del Seguro Social; México 2003.
24. Sibai BM, Mercer B, Schiff E, Friedman S. Aggressive versus expectant management of severe preeclampsia at 28-32 weeks' gestation: a randomized controlled trial Am J Obstet Gynecol 1994; 171:818-822
25. Visser W, Pampus M, Treffers P, Wallenburg H. Perinatal results of homodynamic and conservative temporising treatment in severe preeclampsia. Eur J Obstet Gyn R B 1994; 53:175-181.
26. Schiff E, Friedman S, Sibai B. Conservative management of severe preeclampsia remote from term. Obstet Gynecol 1994; 84:626-630.
27. Friedman SA, Schiff E, Lubarsky SL, Sibai SM. Expectant management of severe preeclampsia remote from term. Clin Obstet Gynecol 1999; 42:470-488.
28. Walker JJ. Care of the patient with severe pregnancy induced hypertension. Eur J Obstet Gyn R B 1996, 65:127-135.
29. Cpage K, Polzin W. Severe preeclampsia and delivery outcomes: is immediate caesarean delivery beneficial? Am J Obstet Gynecol 2002, 186:921-923.